Medicare Enrolled

Dr. Michael Rosario-Prieto, MD

Neuromuscular Medicine (Psychiatry & Neurology) Physician · St Petersburg, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1201 5TH AVE N, St Petersburg, FL 33705
7278207701
Registered in NPPES since 2008
NPI: 1871738948 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosario-Prieto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosario-Prieto? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosario-Prieto

Dr. Michael Rosario-Prieto is a neuromuscular medicine physician in St Petersburg, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rosario-Prieto performed 7,105 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rosario-Prieto received a total of $118,940 from 72 pharmaceutical and/or device companies across 740 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosario-Prieto is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 12% volume in FL $118,940 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
7,105
Medicare services
Top 12% in FL for neuromuscular medicine (psychiatry & neurology) physician
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
6,449 $5 $13
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
122 $89 $311
Injection, methylprednisolone acetate, 40 mg 108 $5 $15
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
86 $126 $421
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
66 $63 $179
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
50 $74 $233
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
32 $92 $257
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
29 $77 $188
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $57 $221
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $122 $408
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
26 $127 $498
New patient office visit, complex (60-74 min) 25 $159 $539
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
22 $45 $146
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
15 $161 $510
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
11 $123 $420
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
11 $220 $689
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$118,940
Total received (2018-2024)
Avg $16,991/year across 7 years
Top 12% in FL for neuromuscular medicine (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
740
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$76,001
2023
$24,979
2022
$11,681
2021
$1,200
2020
$705
2019
$2,144
2018
$2,231

Payments by company (2024)

UCB, Inc.
$52,090
ARGENX US, INC.
$14,762
UCB SA
$3,995
Amgen Inc.
$2,286
ABBVIE INC.
$350
MITSUBISHI TANABE PHARMA AMERICA, INC.
$334
Takeda Pharmaceuticals U.S.A., Inc.
$258
PFIZER INC.
$183
Novartis Pharmaceuticals Corporation
$173
Lundbeck LLC
$167
Alexion Pharmaceuticals, Inc.
$156
Lilly USA, LLC
$155
Neurocrine Biosciences, Inc.
$105
Biogen, Inc.
$102
Merz Pharmaceuticals, LLC
$92
CATALYST PHARMACEUTICALS, INC.
$86
GE HEALTHCARE
$81
Eisai Inc.
$77
Sumitomo Pharma America, Inc.
$74
Vanda Pharmaceuticals Inc.
$62
Sarepta Therapeutics, Inc.
$57
Acorda Therapeutics, Inc
$53
Genentech USA, Inc.
$41
Neurelis, Inc.
$40
SK Life Science, Inc.
$35
Alnylam Pharmaceuticals Inc.
$29
CSL Behring
$26
ACADIA Pharmaceuticals Inc
$26
Xeris Pharmaceuticals, Inc.
$25
LivaNova USA, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
ITF Therapeutics LLC
$17
Teva Pharmaceuticals USA, Inc.
$14
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 93.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$61,928
ARGENX US, INC.
$37,676
UCB SA
$3,995
Amgen Inc.
$2,471
Alexion Pharmaceuticals, Inc.
$1,578
Piramal Critical Care
$886
Novartis Pharmaceuticals Corporation
$682
Teva Pharmaceuticals USA, Inc.
$575
ABBVIE INC.
$556
Genentech USA, Inc.
$543
Allergan, Inc.
$480
Biogen, Inc.
$461
Takeda Pharmaceuticals U.S.A., Inc.
$446
MITSUBISHI TANABE PHARMA AMERICA, INC.
$394
AbbVie Inc.
$391
Allergan Inc.
$377
PFIZER INC.
$360
CSL Behring
$342
Lilly USA, LLC
$327
Neurocrine Biosciences, Inc.
$308
GE HealthCare
$304
Lundbeck LLC
$287
Acorda Therapeutics, Inc
$284
SK Life Science, Inc.
$242
GE HEALTHCARE
$200
ACADIA Pharmaceuticals Inc
$188
Eisai Inc.
$166
Sunovion Pharmaceuticals Inc.
$161
PORTOLA PHARMACEUTICALS, INC.
$159
Sumitomo Pharma America, Inc.
$147
Silk Road Medical, Inc.
$138
CATALYST PHARMACEUTICALS, INC.
$137
Supernus Pharmaceuticals, Inc.
$131
GENZYME CORPORATION
$122
EMD Serono, Inc.
$94
Upsher-Smith Laboratories LLC
$94
Merz Pharmaceuticals, LLC
$92
Sarepta Therapeutics, Inc.
$82
Grifols USA, LLC
$74
BANNER LIFE SCIENCES, LLC
$72
Jazz Pharmaceuticals Inc.
$68
Alnylam Pharmaceuticals Inc.
$67
Biohaven Pharmaceutical Holding Company Ltd.
$66
Xeris Pharmaceuticals, Inc.
$65
Vanda Pharmaceuticals Inc.
$62
AstraZeneca Pharmaceuticals LP
$61
Neurelis, Inc.
$40
Avanir Pharmaceuticals, Inc.
$39
Biohaven Pharmaceuticals, Inc.
$38
Horizon Pharma plc
$32
Catalyst Pharmaceuticals, Inc.
$32
Harmony Biosciences LLC
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
Zyla Life Sciences, Inc.
$28
UPSHER-SMITH LABORATORIES LLC
$26
US WorldMeds, LLC
$26
Egalet US Inc
$24
Banner Life Sciences, LLC
$24
JAZZ PHARMACEUTICALS INC.
$24
Vertical Pharmaceuticals, LLC
$21
LivaNova USA, Inc.
$20
EISAI INC.
$19
Corium, LLC
$19
ITF Therapeutics LLC
$17
Promius Pharma LLC
$17
Amylyx Pharmaceuticals, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$16
Kyowa Kirin, Inc.
$16
Celgene Corporation
$13
PTC Therapeutics, Inc.
$13
PORTOLA PHARMACEUTICALS, LLC
$12
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 87.1% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Actemra · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · EMFLAZA · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · EVUSHELD · Elevidys · Evrysdi · Exondys 51 · FIRDAPSE · Fintepla · Fycompa · GABLOFEN 1 mL in 1 SYRINGE · GAMMAGARD · GILENYA · GLASS · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LUMIZYME · Leqembi · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PONVORY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RAYOS · RELEXXII · RELYVRIO · REXULTI · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · TAVNEOS · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XCOPRI · XYREM · XYWAV · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neuromuscular medicine physician in St Petersburg?
Compare neuromuscular medicine physicians in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse neuromuscular medicine physicians nearby

Geographic Context

Neuromuscular medicine physicians in nearby ZIP areas
1
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ST ANTHONYS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rosario-Prieto is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rosario-Prieto experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rosario-Prieto performed 6,449 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rosario-Prieto receive payments from pharmaceutical companies?
Yes. Dr. Rosario-Prieto received a total of $118,940 from 72 companies across 740 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosario-Prieto's costs compare to other neuromuscular medicine physicians in St Petersburg?
Dr. Rosario-Prieto's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosario-Prieto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →